Published in Cancer Weekly, May 18th, 2004
Bowel tumors are often resistant to individual chemotherapy drugs. Giving patients only those drugs that are likely to work would give them their best chance of benefit as well as freeing them of unnecessary side effects.
The team - working under Professor Patrick Johnston at Belfast City Hospital - published their findings in Clinical Cancer Research and plan to use the knowledge to create an exciting new tool in the fight against bowel cancer.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.